Izotropic Corporation | News
  • CSE: IZO
  • OTCQB: IZOZF
  • FSE: 1R3
Menu
8/7/2025
Izotropic Launches Podcast Episode #1: Beyond the Mammogram: Rethinking the Future of Breast Imaging
VIEW
8/5/2025
Izotropic’s IzoView Positioned to Capitalize on Key Global Breast Imaging Market Drivers
VIEW
7/29/2025
Izotropic’s IzoView Breast CT Device Stands Distinct vs Existing Breast Imaging Technologies
VIEW
7/15/2025
Izotropic Prepares New Platforms to Educate and Engage
VIEW
6/13/2025
Izotropic Provides Marketing Update
VIEW
6/10/2025
Izotropic Updates License Agreement Terms with University of California
VIEW
5/16/2025
Izotropic’s U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update
VIEW
4/2/2025
Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender
VIEW
3/25/2025
Izotropic Completes Pre-Submission Meeting with FDA for Breast Cancer Screening Indication
VIEW
3/10/2025
Izotropic to Present at Investor Conference March 13th
VIEW
2/19/2025
FDA Sets Meeting Date with Izotropic
VIEW
2/14/2025
Izotropic Closes Non-Brokered Private Placement
VIEW
2/7/2025
Izotropic Announces Non-Brokered Private Placement- February 2025
VIEW
1/29/2025
Izotropic Announces Timelines and Milestones to IzoView Product Launch
VIEW
1/17/2025
Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast
VIEW
1/15/2025
Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions
VIEW
1/9/2025
Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening
VIEW